
Aunt Teefa
1.2K posts

Aunt Teefa
@aunt_teefa
🇺🇸🏳️🌈 Welcome snowflakes! Here to shit on republicans.


RuPaul talks about the rise of fascism in a new video.


@donie They literally bought that baby and ripped it from his mother. Disgusting.


@donie It’s creepy af that 2 gay men want to have a baby..




Mifepristone is safe and effective health care, and access to health care should be a right for every American.






$LLY | Eli Lilly Q1 Earnings Highlights 🔹 Revenue: $19.80B (Est. $17.77B) 🟢; +56% YoY 🔹 Adj. EPS: $8.55 (Est. $7.06) 🟢; +156% YoY 🔹 Mounjaro: $8.66B (Est. $7.21B) 🟢; +125% YoY 🔹 Zepbound: $4.16B (Est. $4.03B) 🟢; +80% YoY 🔹 FDA Approval: Foundayo, Lilly’s oral GLP-1 pill for obesity Raises FY26 Guide: 🔹 Revenue: $82B-$85B (Est. $80B) 🟢; raised from $80.0B-$83.0B 🔹 Adj. EPS: $35.50-$37.00 (Est. $33.50) 🟢; raised from $33.50-$35.00 🔹 Performance Margin: 47.0%-48.5%; raised from 46.0%-47.5% 🔹 Tax Rate: 18%-19%; unchanged Other Metrics: 🔹 Key Products Revenue: $13.4B 🔹 U.S. Revenue: $12.1B; UP +43% YoY 🔹 Revenue Outside U.S.: $7.7B; UP +81% YoY 🔹 Worldwide Volume Growth: +65% 🔹 Realized Prices: DOWN -13% 🔹 Acquired IPR&D Charges: $584M vs $1.6B YoY 🔹 Q1 EPS included $0.52 of acquired IPR&D charges vs $1.72 YoY Financials: 🔹 Non-GAAP Gross Margin: 82.6%; DOWN -0.9 pts YoY 🔹 R&D Expense: $3.5B; UP +28% YoY 🔹 Marketing, Selling & Admin Expense: $2.9B; UP +19% YoY 🔹 Non-GAAP Net Income: $7.7B; UP +155% YoY 🔹 Non-GAAP Tax Rate: 16.5% Commentary: 🔸 “2026 is off to a strong start, we delivered 56% revenue growth in the first quarter and raised our full-year revenue guidance by $2 billion.” 🔸 “A key milestone was the U.S. FDA approval of Foundayo—the only approved GLP-1 pill that can be taken any time of day, without food and water restrictions.” 🔸 “Foundayo will meaningfully expand the number of people who can benefit from GLP-1s.”



NOT HER CRYING LMFAOOOOOOO😭😭😭


How do we coexist with people that want to murder us?










